Compugen Ltd.
ANTI-PVRIG/ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF USE
Last updated:
Abstract:
Anti-PVRIG, anti-TIGIT, and anti-PVRIG/anti-TIGIT bispecific antibodies are provided, as well as compositions, and methods of using the antibodies for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
31 May 2019
Issue date:
19 Dec 2019